India Globalization Capital, Inc. (IGC) Stock Rises Over 10% After This News

On Thursday. June 24, 2021, India Globalization Capital, Inc. (IGC) announced that it has completed cohort 3 of its phase 1 clinical trial conducted of IGC’s tetrahydrocannabinol based investigational drug, IGC-AD1. The stock closed at $1.65 and made a change of +0.17 and a percentage change of +11.49% during the market trading hours. The impact initiated during the premarket watch The news of IGC’s completion of its drug pushed the stock in such a way that it had a gap opening in the day trading graph.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.

Sponsored


Breaking down the news

India globalization capital Inc. produces cannabinoid-based therapies for the treatment of Alzheimer’s disease.  Earlier this month IGC announced the completion of the cohort 2 drug trial which lifted the stock by 27%. After, declaring the completion of its cohort 3 trials, the IGC stock rose as high as 35% in recent trading. To IGC’s knowledge, it is one of its kind medication to be tested on humans using a low dosage of THC, a psychoactive member of the cannabinoid class of product produced by the cannabis Sativa plant.  If the drug trials become successful, IGC-AD1 could provide some relief for 50 million people around the world expected to be impacted by Alzheimer’s disease by 2030.

During mid of this month on 15th June 2021, IGC published its financial results for the fiscal year 2021. Revenues were reported approximately $898 thousand compared to $4.1 million in the fiscal year 2020. On the other hand, net loss was reported at approximately $8.8 million or $0.21 per share, compared to approximately $7.3 million or $0.19 per share for the fiscal year 2020.

Is IGC Stock a Buy?

India globalization capital Inc. holds several positive signals. At this current position, it should be observed closely for further development. Those who have any positions in the stock should hold them for further development.

Latest

The Chart for Block Inc. (SQ) Stock Is Flashing Mixed Signals

In the first quarter, large investment funds expanded their...

What to Expect When Snap Inc. (SNAP) Reports Quarterly Earnings?

Snapchat, a social media platform owned by Snap Inc....

Getting Sustainable Earnings? Movado Group Inc. (MOV)

Movado Group Inc. (NYSE: MOV), the owner of the...

Future Prospects Brighter For Red Cat Holdings Inc. (RCAT) Stock

The US Army has awarded Red Cat Holdings, Inc....

Newsletter

 

Don't miss

Healthy Upside Potential: Maxar Technologies Ltd. (MAXR)

In May 25 trading, shares of space business Maxar...

Atkore Inc. (ATKR) stock: Better Than You Think

Atkore Inc. (NYSE:ATKR), a manufacturer of infrastructure, electrical, and...

Provention Bio, Inc. (PRVB) Having a Robust Premarket After Abysmal Thursday

Provention Bio, Inc. (PRVB), a clinical stage biopharmaceutical company,...

Farmmi, Inc. (FAMI) Stock Soaring in Premarket, Here’s the Reason

Farmmi, Inc. (FAMI), a company that processes and sells...

Ulta Beauty Inc. (ULTA) last month performance of -6.16% certainly makes it a sizzling prospect

Ulta Beauty Inc. (NASDAQ: ULTA) open the trading on May 26, 2022, with great promise as it jumped 7.09% to $377.96. During the day,...

The key reasons why Alset EHome International Inc. (AEI) is -95.54% away from 52-week high?

Witnessing the stock’s movement on the chart, on May 26, 2022, Alset EHome International Inc. (NASDAQ: AEI) set off with pace as it heaved...

StoneCo Ltd. (STNE) latest performance of 2.97% is not what was on cards

StoneCo Ltd. (NASDAQ: STNE) established initial surge of 2.97% at $9.71, as the Stock market unbolted on May 26, 2022. During the day, the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here